Longo F, Mercatelli D, Novello S, Arcuri L, Brugnoli A, Vincenzi F, et al. Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice. Acta Neuropathol Commun. 2017;5:22 pubmed publisher

Schmitt M, Dehay B, Bezard E, Garcia Ladona F. Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line. Synapse. 2016;70:71-86 pubmed publisher

Yaoita F, Tsuchiya M, Arai Y, Tadano T, Tan No K. Involvement of catecholaminergic and GABAAergic mediations in the anxiety-related behavior in long-term powdered diet-fed mice. Neurochem Int. 2019;124:1-9 pubmed publisher

Romay Tallon R, Kulhawy E, Brymer K, Allen J, Rivera Baltanas T, Olivares J, et al. Changes in Membrane Protein Clustering in Peripheral Lymphocytes in an Animal Model of Depression Parallel Those Observed in Naïve Depression Patients: Implications for the Development of Novel Biomarkers of Depression. Front Pharmacol. 2018;9:1149 pubmed publisher

Pinto M, Nissanka N, Moraes C. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease. J Neurosci. 2018;38:1042-1053 pubmed publisher

Volta M, Beccano Kelly D, Paschall S, Cataldi S, Macisaac S, Kuhlmann N, et al. Initial elevations in glutamate and dopamine neurotransmission decline with age, as does exploratory behavior, in LRRK2 G2019S knock-in mice. elife. 2017;6: pubmed publisher

Garea Rodríguez E, Eesmaa A, Lindholm P, Schlumbohm C, König J, Meller B, et al. Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease. PLoS ONE. 2016;11:e0149776 pubmed publisher

Cummins E, Griffin S, Burgess K, Peterson D, Watson B, Buendia M, et al. Methylphenidate place conditioning in adolescent rats: an analysis of sex differences and the dopamine transporter. Behav Brain Res. 2013;257:215-23 pubmed publisher